PUMA BIOTECHNOLOGY, INC.
Ownership & governance
Executives 5Directors 8Avg age 62Avg tenure 9.5y
AA
Alan Auerbach
Chief Executive Officer
Age 56Since 2010-09-14Profile →
+12
Executives5
AA
Alan Auerbach→
Chief Executive Officer
Age 56Since 2010-09-14
MN
Maximo Nougues→
Director of Finance/CFO
Age 57Since 2018-11-04
PR
Petra Rietschel→
Chief Tech/Sci/R&D Officer
—Since 2026-03-31
PW
Pamela Wilson→
Chief Tech/Sci/R&D Officer
—Since 2013-11-30
AW
Alvin Wong→
Chief Tech/Sci/R&D Officer
Age 73Since 2017-07-31
Board of directors8
AA
Alan Auerbach→
Chairman
Age 56Since 2010-09-14
JM
Jay Moyes→
Director/Board Member
Age 72Since 2012-04-26
TW
Troy Wilson→
Director/Board Member
Age 57Since 2013-10-17
AS
Adrian Senderowicz→
Director/Board Member
Age 62Since 2015-08-10
MM
Michael Miller→
Director/Board Member
Age 69Since 2018-02-22
BS
Brian Stuglik→
Director/Board Member
Age 66Since 2020-07-04
AD
Allison Dorval→
Director/Board Member
Age 50Since 2021-07-14
AC
Alessandra Cesano→
Director/Board Member
Age 65Since 2022-07-28
Shareholders5
| Name | Stake | Shares |
|---|---|---|
| Alan Auerbach | 13.84 % | 7,046,751 |
| Acorn Capital Advisors LLC | 8.117 % | 4,131,299 |
| BlackRock Advisors LLC | 6.701 % | 3,410,979 |
| Acadian Asset Management LLC | 4.011 % | 2,041,759 |
| Renaissance Technologies LLC | 3.816 % | 1,942,413 |
Catalog · 2026-07-09
Registry officers13
| Name | Role | Since | Shares |
|---|---|---|---|
| Alan Auerbach | Chairman | 2010-09-14 | - |
| Alan Auerbach | Chief Executive Officer | 2010-09-14 | - |
| Alvin Wong | Chief Tech/Sci/R&D Officer | 2017-07-31 | - |
| Maximo Nougues | Director of Finance/CFO | 2018-11-04 | - |
| Pamela Wilson | Chief Tech/Sci/R&D Officer | 2013-11-30 | - |
| Petra Rietschel | Chief Tech/Sci/R&D Officer | 2026-03-31 | - |
| Adrian Senderowicz | Director/Board Member | 2015-08-10 | - |
| Alessandra Cesano | Director/Board Member | 2022-07-28 | - |
Registry · as of 2026-07-09
Institutional (13F)
Loading Form 13F holders…
Fund membership
Loading fund baskets…
Street consensus
Consensus none
- Hold 1
Broker actions40 of 81
| Firm | Action | To | Target | Date |
|---|---|---|---|---|
| TD Cowen | Maintained | Hold | 6 | 2026-08-07 |
| HC Wainwright & Co. | Reiterated | Buy | 7 | 2025-02-28 |
| HC Wainwright & Co. | Reiterated | Buy | 7 | 2024-12-23 |
| HC Wainwright & Co. | Reiterated | Buy | 7 | 2024-11-20 |
| HC Wainwright & Co. | Reiterated | Buy | 7 | 2024-11-08 |
| HC Wainwright & Co. | Reiterated | Buy | 7 | 2024-08-02 |
| HC Wainwright & Co. | Reiterated | Buy | 7 | 2024-07-26 |
| HC Wainwright & Co. | Reiterated | Buy | 7 | 2024-06-04 |
| HC Wainwright & Co. | Reiterated | Buy | 7 | 2024-06-03 |
| HC Wainwright & Co. | Reiterated | Buy | 7 | 2024-05-20 |
| HC Wainwright & Co. | Reiterated | Buy | 7 | 2024-05-03 |
| HC Wainwright & Co. | Maintained | Buy | 7 | 2024-03-01 |
Firm rows and rating mix from Yahoo Finance; mean target is Yahoo’s aggregate until OpenFilings derives consensus from broker rows.